Robert J. Spiegel Insider Trading $ATNX Athenex, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Robert J. Spiegel.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Robert J. Spiegel. Robert J. Spiegel is Director in Capstone Therapeutics Corp. ($CAPS) and Director in GERON CORP ($GERN) and Director in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Chief Medical Officer in PTC THERAPEUTICS, INC. ($PTCT) and Director in Athenex, Inc. ($ATNX) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in Edge Therapeutics, Inc. ($EDGE).

Robert J. Spiegel in Athenex, Inc.

Trading Symbol: ATNX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert J. Spiegel: Director
Holdings: 0 shares
Latest Transaction: Aug 12 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Robert J. Spiegel in Athenex, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ATNX, CAPS, CYCC, GERN, EDGE, PTCT, SCMP

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 12 2020ATNXAthenex, Inc.Spiegel Robert J.DirectorOption ExerciseA11.407,29283,1297,292

Page:   1